Yatharth Hospital & Trauma Care ServicesQ1 FY25

Yatharth Hospital & Trauma Care Services Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,109.55P/E: 56.1Market Cap: ₹10.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • Expect revenue close to INR 1000 crores this year, driven by growth across facilities (Page 17).
  • Inpatient volume grew 28% YoY to 15,235 this quarter, with notable growth in Noida Extension (81% revenue increase, 38% contribution) (Pages 5, 9).
  • ARPOB (Average Revenue Per Occupied Bed) is improving, reaching INR 30,551 in Q1; expected to increase further with improved case mix and pricing (Pages 5, 17).
  • Capacity expansion underway: 200 beds in Greater Noida and 250 beds in Noida Extension planned within 2-2.5 years, expected to achieve over 50% utilization within two years post-expansion (Pages 11, 17).
  • Addition of 3,000 beds targeted by FY 2028 via brownfield expansions, acquisitions, and O&M models, primarily in North India, Delhi NCR, UP, and Rajasthan (Pages 7, 11-12).
  • Faridabad hospital occupancy to grow from current 10% to 30% by year-end, contributing to revenues (Page 10).
  • Oncology and super-specialty services expected to increase contribution and ARPOB, supporting volume growth (Pages 5, 9).

See what Yatharth Hospital & Trauma Care Services management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
  • The company currently has cash of INR 1,826 million and has reduced finance costs after IPO, improving capital efficiency.
  • Future expansions, including adding roughly 450 beds at Greater Noida and Noida Extension in 2-2.5 years, are expected to be funded largely through internal accruals.
  • There is scope for taking on additional debt if required, though efforts are made to utilize internal accruals and existing cash.
  • The company is also exploring acquisition opportunities, including operational and management (O&M) models, which require less capital outlay.
  • Overall, the financing strategy for growth includes a mix of internal accruals, available cash, and selective debt, with no specific mention of planned equity fundraising in the near term.

See what Yatharth Hospital & Trauma Care Services management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Brownfield expansions at Noida Extension and Greater Noida hospitals: adding 250 beds at Noida Extension and 200 beds at Greater Noida, expected in 2-2.5 years, with capex around INR 65 lakh per bed funded through internal accruals.
  • Capex increased by INR 60 crores this quarter primarily due to medical equipment including robotics and advanced surgical tools for neurosurgery and cardiac surgeries.
  • Strategic investments in robotics and super-specialty services, including oncology and organ transplant programs.
  • Plans for further bed capacity expansion aiming to reach 2,800 to 3,000 beds by FY '28 through a mix of internal accruals, debt, and O&M model acquisitions to limit asset-heavy outflows.
  • Ongoing efforts to acquire new hospitals, with recent acquisitions in Jhansi-Orchha and Faridabad, and active discussions for two more hospitals in Delhi NCR and Uttar Pradesh.
  • Signing NDA with major audit firms for process strengthening, indicating strategic governance investments.

Track Yatharth Hospital & Trauma Care Services — get its next earnings analysis in your feed

How does Yatharth Hospital & Trauma Care Services rank vs peers in Healthcare Services?

Pro feature
ThisYatharth Hospital & Trauma Care Services
Rev 2Mar 3

How does Yatharth Hospital & Trauma Care Services rank in Healthcare Services?

Compare Yatharth Hospital & Trauma Care Services against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →